| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1998 | 2020 | ||||||||
|
serpin family A member 5 | 0.507 | 0.808 | 6.2E-09 |
|
disease | 0.100 | None | 0.962 | 26 | 0 | 2017 | 2019 | ||||||||
|
purinergic receptor P2Y12 | 0.533 | 0.731 | 1.7E-03 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2020 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.100 | None | 0.960 | 25 | 0 | 1993 | 2020 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.100 | None | 0.880 | 25 | 0 | 2001 | 2019 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2001 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 2003 | 2018 | ||||||||
|
phospholipase A2 group IIA | 0.488 | 0.808 | 9.7E-02 |
|
disease | 0.100 | None | 0.950 | 20 | 0 | 1997 | 2015 | ||||||||
|
TNF receptor superfamily member 11b | 0.422 | 0.808 | 0.16 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 2004 | 2019 | ||||||||
|
phosphate cytidylyltransferase 1, choline, alpha | 0.485 | 0.885 | 2.0E-05 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 2017 | 2019 | ||||||||
|
choline dehydrogenase | 0.529 | 0.769 | 1.7E-06 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 1999 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2008 | 2019 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1999 | 2017 | ||||||||
|
mannose phosphate isomerase | 0.585 | 0.654 | 1.2E-07 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2017 | 2020 | ||||||||
|
competing endogenous lncRNA 3 for miR-645 | 0.531 | 0.808 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 2017 | 2019 | |||||||||
|
phospholipase A2 group VI | 0.476 | 0.846 | 2.5E-10 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 1997 | 2015 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2010 | 2019 | |||||||||
|
resistin | 0.454 | 0.808 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2006 | 2019 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2004 | 2017 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1998 | 2019 | ||||||||
|
gap junction protein alpha 4 | 0.663 | 0.500 | 5.6E-02 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2003 | 2018 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2000 | 2018 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2003 | 2018 | ||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2010 | 2019 | |||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2001 | 2018 |